Syncom Formulations (India) Limited — Board Meeting, 11-08-2026: Outcome of Board Meeting
11-08-2026 | 06:49 pm
11-08-2026 | 06:49 pm
Syncom Formulations' board approved the financial results for the quarter ended June 30, 2026. Consolidated Revenue hit Rs 125.53 Cr, with a net profit of Rs 24.85 Cr. Basic EPS for the quarter was Rs 0.26.
No comments yet. Be the first to comment!
